-

908 Devices Expands Strategic Distribution Network in APAC, Europe, and the Americas

Channel expansion creates momentum for growth of handheld and desktop products internationally

BOSTON--(BUSINESS WIRE)--908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the expansion of its channel distribution network, adding new international traction and momentum. 908 Devices handheld and desktop devices are now available across six continents in more than 40 countries and configured in any of six languages.

“One of our 2021 goals is to drive expansion across our sales channels, customers, and platforms. We are investing significant resources to support our sales organization, partners, and customers to achieve this goal,” said Kevin J. Knopp, CEO and Co-Founder of 908 Devices. “We’ve recently added highly trusted organizations in key regions to our network to support customer demand. We are excited for the impact to come from these regions.”

908 Devices newest distribution partners include:

  • Sartorius Korea Biotech Co. Ltd. – A leading company in South Korea specializing in providing complete workflows across biopharma process development, manufacturing, and quality control.
  • Rhenium Ltd. – As one of the largest distribution companies in the laboratory equipment industry in Israel, Rhenium provides products, equipment, and support for academic, medical, and forensics laboratories and commercial companies.
  • Noster Tec SRL – A Bolivian-based group that supports civil defense and investigation analytical technologies.
  • Innovatek – A Colombian company that supports reliable, consistent, and convenient laboratory and field-based analytical equipment.
  • Provetecnia S.A. de C.V. – Based in Mexico, Provetecnia specializes in the maintenance, distribution, and installation of high-quality security systems.
  • Raytech – A Polish supplier of modern portable and mobile chemical analysis devices.

To support this expanding distribution network, 908 Devices has also added sales managers, support, and application employees across England, Scotland, France, Germany, Belgium, Denmark, Netherlands, Chile, and China.

“We have been fortunate to be able to add top talent to our team not only in sales and support functions, but industry subject matter experts too,” said Maura Fitzpatrick, VP Product Management & Marketing. “We’ve recently added several individuals with deep domain and business development expertise in forensics, biopharma, and bioprocessing to further support our global channel and serve as a resource to our customers. We are working aggressively to drive international expansion, and these key hires are instrumental in helping us achieve our goals.”

To learn more about 908 Devices, please visit: 908devices.com.

About 908 Devices

908 Devices (NASDAQ:MASS) is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma / biopharma, forensics, and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic separations, software automation, and machine learning.

Contacts

Media Contact
Katie Johnston
PAN Communications for 908 Devices
908devices@pancomm.com

Investor Contact
Carrie Mendivil
IR@908devices.com

908 Devices

NASDAQ:MASS

Release Versions

Contacts

Media Contact
Katie Johnston
PAN Communications for 908 Devices
908devices@pancomm.com

Investor Contact
Carrie Mendivil
IR@908devices.com

More News From 908 Devices

908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld devices for chemical analysis, announces that it has received a $1.7 million order from the Ministry of Health of Ukraine for its MX908 handheld mass spectrometry device with Aero module for priority shipment in the first quarter 2025. The devices will be part of an environmental testing kit in a post-war environment and will be used primarily to detect and identify trace substances of hazardous materi...

908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter and full year ended December 31, 2024. Strategic Transformation Realized 908 Devices cements its unique position as a market-leading provider of analytical tools for tackling critical public health and safety crises through the divestiture of its bioprocessing desktop assets to Repligen Corporation. This transac...

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

WALTHAM, Mass., & BOSTON--(BUSINESS WIRE)--Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld and desktop devices for chemical analysis, announce that Repligen has purchased 908 Devices’ desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. 908 Devices remains focused on the growth of its newly expanded handheld device...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.